---
document_datetime: 2023-09-21 20:00:19
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/referral/protelos-and-osseor-article-20-procedure-timetable-procedure_en.pdf
document_name: protelos-and-osseor-article-20-procedure-timetable-procedure_en.pdf
version: success
processing_time: 1.7178263
conversion_datetime: 2025-12-14 13:49:16.713659
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
<!-- image -->

5 September 2013 EMA/PRAC/283428/2013 rev1

| Procedural step:                                                                      | Date no             |
|---------------------------------------------------------------------------------------|---------------------|
| Notification:                                                                         | 25/04/2013 product  |
| Start of procedure (PRAC):                                                            | 16/05/2013          |
| List of questions:                                                                    | 16/05/2013          |
| Submission of responses:                                                              | 12/06/2013          |
| Re-start of the procedure                                                             | 08/07/2013          |
| Rapporteur/co-rapporteur assessment reports circulated to PRAC and to CHMP: Medicinal | 26/07/2013          |
| Comments:                                                                             | 14/08/2013          |
| Updated rapporteur/co-rapporteur assessment reports circulated to PRAC and to CHMP:   | 20/08/2013          |
| PRAC List of Outstanding Issues:                                                      | September 2013 PRAC |
| Ad-hoc expert meeting:                                                                | 10/09/2013          |

Timetable for the procedure Review under Article 20 of Regulation (EC) No 726/2004, following the procedural steps laid out in Article 31 of Directive 2001/83/EC Procedure number: Protelos EMEA/H/A20/1371/C/000560/0039 Osseor EMEA/H/A20/1371/C/000561/0034 INN: strontium ranelate Medicinal product no longer authorised

7 Westferry Circus ● Canary Wharf ● London E14 4HB ● United Kingdom

Telephone

+44 (0)20 7418 8400

Facsimile

+44 (0)20 7418 8668

E-mail

info@ema.europa.eu

Website

www.ema.europa.eu

<!-- image -->

<div style=\"page-break-after: always\"></div>

| Procedural step:                                                                    | Date              |
|-------------------------------------------------------------------------------------|-------------------|
| Submission of responses:                                                            | 04/11/2013        |
| Re-start of the procedure                                                           | 11/11/2013        |
| Rapporteur/co-rapporteur assessment reports circulated to PRAC and to CHMP:         | 01/12/2013        |
| Comments:                                                                           | 15/12/2013        |
| Updated rapporteur/co-rapporteur assessment reports circulated to PRAC and to CHMP: | 19/12/2013        |
| Oral Explanation PRAC List of Outstanding Issues or PRAC recommendation to CHMP:    | January 2014 PRAC |

Medicinal product no longer authorised